Benzinga · Aug 5, 2026
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $7.5
Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and raises the price target from $6.5 to $7.5.
CE
NASDAQ · CERT
Certara, Inc.
Healthcare · Medical - Healthcare Information Services
$8.00
Down-$0.15 (-1.84%)
Updated Aug 16, 2026, 11:59 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.42B
- P/E ratio
- 177.53
- Dividend yield
- 0.00%
- 52-week range
- $4.45 – $8.39
- Volume
- 1.43M
- Avg. volume
- 2.12M
Price performance
CERT price history
1M range · 20 trading sessions · Daily adjusted prices
CERT closed at $8.00 after 20 trading sessions, up 15.27% for the selected period.
- Last close
- $8.00
- Period change
- +15.27%
- Period low
- $6.85
- Period high
- $8.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $8.26 | $8.29 | $7.95 | $8.00 | 1.43M |
| Aug 13, 2026 | $8.00 | $8.21 | $7.855 | $8.15 | 5.42M |
| Aug 12, 2026 | $8.13 | $8.18 | $7.94 | $8.01 | 3.34M |
| Aug 11, 2026 | $8.08 | $8.225 | $8.02 | $8.13 | 2.36M |
| Aug 10, 2026 | $8.13 | $8.18 | $7.985 | $8.07 | 3.06M |
| Aug 7, 2026 | $8.13 | $8.285 | $8.06 | $8.20 | 2.23M |
| Aug 6, 2026 | $8.01 | $8.175 | $7.944 | $8.13 | 5.79M |
| Aug 5, 2026 | $7.95 | $8.16 | $7.895 | $8.01 | 3.41M |
| Aug 4, 2026 | $6.332 | $7.825 | $6.332 | $7.80 | 10.8M |
| Aug 3, 2026 | $8.275 | $8.39 | $8.03 | $8.18 | 3.67M |
| Jul 31, 2026 | $7.80 | $8.145 | $7.70 | $8.10 | 4.44M |
| Jul 30, 2026 | $7.99 | $8.05 | $7.682 | $7.78 | 5.16M |
| Jul 29, 2026 | $7.87 | $8.17 | $7.83 | $8.09 | 4.12M |
| Jul 28, 2026 | $7.80 | $8.235 | $7.75 | $7.91 | 5.06M |
| Jul 27, 2026 | $7.64 | $7.895 | $7.58 | $7.75 | 4.26M |
| Jul 24, 2026 | $7.13 | $7.60 | $7.13 | $7.51 | 5.62M |
| Jul 23, 2026 | $6.91 | $7.15 | $6.875 | $7.11 | 3.35M |
| Jul 22, 2026 | $6.96 | $6.98 | $6.69 | $6.89 | 2.07M |
| Jul 21, 2026 | $6.81 | $6.985 | $6.75 | $6.85 | 2.64M |
| Jul 20, 2026 | $6.95 | $7.03 | $6.82 | $6.94 | 1.94M |
Latest CERT news
The latest Smart Investors Daily articles mentioning CERT.
Stock researchCompany · Overview
CERT research
Overview
Company profile and research snapshot.
Company profile
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $13.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | Barclays | Equal-Weight | — |
| May 12, 2026 | BMO Capital | Market Perform | — |
| May 12, 2026 | Craig-Hallum | Hold | — |
| May 12, 2026 | Stephens & Co. | Overweight | — |
| May 12, 2026 | Barclays | Equal-Weight | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 4, 2026
Certara, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-04. The following slide deck was published by Certara, Inc.
SeekingAlpha · Aug 4, 2026
Certara, Inc. (CERT) Q2 2026 Earnings Call Transcript
Certara, Inc. (CERT) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsJon Resnick - CEO & DirectorFaiz Mohammed - Interim CFO, Senior...
Benzinga · Aug 4, 2026
Transcript: Certara Q2 2026 Earnings Conference Call
Certara (NASDAQ:CERT) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
